List view / Grid view

bioMérieux

 

article

The future of CMC for novel therapies

22 April 2022 | By

Novel and advanced therapies have come on in leaps and bounds over the past decade. Some cell and gene therapies have already reached the approvals stage, while others have now entered the later development stages. As a result, manufacturing process consistency, GMP standards and more must now meet more formal…